Vulvar Diseases: Clinical Trials

501 trials for Vulvar Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

261 completed, 79 recruiting, 57 unknown, 34 terminated. 178 Not applicable, 107 Phase 2, 63 Phase 3, 52 Phase 1, 13 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable178Completed 91, Unknown 25, Recruiting 24, Active not recruiting 12, Terminated 12, Not yet recruiting 9, Withdrawn 4, Enrolling by invitation 1
Phase 2107Completed 42, Recruiting 26, Terminated 12, Unknown 9, Active not recruiting 8, Not yet recruiting 6, Withdrawn 4
Phase 363Completed 45, Unknown 6, Terminated 4, Recruiting 3, Not yet recruiting 2, Withdrawn 2, Active not recruiting 1
Phase 152Completed 34, Recruiting 9, Unknown 5, Terminated 2, Active not recruiting 1, Not yet recruiting 1
Phase 413Completed 8, Unknown 3, Not yet recruiting 1, Recruiting 1
Early Phase 16Completed 3, Recruiting 2, Active not recruiting 1

Follow Vulvar Diseases: new trials by email Literature Review of Vulvar Diseases trials Research Report on Vulvar Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study on the Efficacy of Oral Low Dose Naltrexone for Vulvodynia
Low Dose Naltrexone - Vulvodynia
Phase 2Not yet recruitingUniversity of Florida202027-01-012026-10-09
Transcutaneous Genital Nerves Stimulation for the Treatment of Refractory Chronic Pelvic and Genital Pain in Women.
Transcutaneous Genital Nerves Stimulation - Refractory Visceral Pelvic Pain, Refractory Genital Pain
Not applicableNot yet recruitingProf. Dr. med. Marc Possover502026-12-012026-10-20
Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva
Tisotumab Vedotin - Vulvar Carcinoma, Recurrent or Metastatic Vulvar Cancer
Phase 2Not yet recruitingGOG Foundation282026-11-012026-06-29
Needlefree Lidocaine Application for Vulvar Biopsies
J-Tip, Lidocaine HCl 1% - Vulvar Cancers, Vulva Neoplasm
Not applicableNot yet recruitingTufts Medical Center1062026-11-012026-08-28
Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions
Routine-care metastasis-directed radiotherapy - Cervical Cancer, Gynecologic Cancer
RecruitingAffidea Nu-med Center of Oncological DIagnostics and Therapy5002026-10-062026-10-20
Comparative Trial Between Open and Single-port Robotic-assisted Groin Lymphadenectomy in Vulvar Cancer
Inguinofemoral lymphadenectomy - Vulvar Cancers
Not applicableNot yet recruitingKarolinska Institutet642026-10-012026-10-01
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Best Practice, Interview, Supportive Care - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Not applicableRecruitingCity of Hope Medical Center1262026-09-092026-10-16
CPP Among Somali Women in Norway: SCED
Multimodal physiotherapy - Chronic Pelvic Pain
Not applicableNot yet recruitingKristiania University College302026-09-012026-09-15
Nemolizumab for LS
Nemolizumab 30 mg - Lichen Sclerosus of Vulva
Phase 2Not yet recruitingUniversity of Texas Southwestern Medical Center252026-09-012026-07-15
Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological Malignancies
Gynecologic Cancer, Cervical Cancer
Not yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS1602026-08-012026-07-14
Photobiomodulation for Vaginal Dysfunctions: Home-Based vs Outpatient Treatment
Blue LED Photobiomodulation - Genitourinary Syndrome of Menopause (GSM), Bacterial Vaginosis
Not applicableNot yet recruitingPatricia Lordelo1502026-07-302026-07-13
Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer
Behavioral Intervention, Educational Intervention, Internet-Based Intervention - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8
Not applicableWithdrawnCity of Hope Medical Center2026-07-162026-02-04
A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer
Becotatug Vedotin in combination with Zimberelimab - Uterine Cervical Neoplasms, Recurrent; Uterine Cervical Neoplasms, Metastatic; Vulvar Neoplasms; Vaginal Neoplasms
Phase 2RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology302026-06-112026-06-16
Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer
Reirradiation, Total Ablative Strategy - Recurrent Gynecologic Cancer, Recurrent Uterine Cancer
RecruitingAffidea Nu-med Center of Oncological DIagnostics and Therapy5002026-06-112026-10-16
Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence
OCF001 Intravaginal Gel, Placebo Gel - Candidiasis, Vulvovaginal
Phase 2RecruitingSano Chemicals Inc362026-06-042026-06-15
Large Algorithm Setting and Validation Study
Nanopath Vaginitis Assay, BD Max™ Vaginal Panel, Cepheid Xpert® Xpress MVP - Bacterial Infections, Bacterial Infections and Mycoses
RecruitingNanopath, Inc10002026-06-032026-07-20
A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer
High-resolution bilateral groin ultrasound monitoring - Vulvar Cancer Stage I, Vulvar Cancer Stage II
Phase 3Not yet recruitingQueensland Centre for Gynaecological Cancer6402026-06-012026-03-24
Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for Vulvovaginal Candidiasis
Bioithas WOMAN® - Vulvovaginal Candidiasis (VVC)
Not applicableRecruitingBioithas SL602026-05-252026-05-22
Efficacy of Dry Needling in Reducing Pain During Sexual Intercourse
Real dry needling, Sham dry needling - Provoked Vestibulodynia
Not applicableRecruitingUniversité de Sherbrooke1702026-05-112026-05-12
Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer
Cervical Cancers, Vaginal Cancers
Enrolling by invitationTampere University Hospital212026-05-012026-05-22

Showing 20 of 501. Sign in to see all of them.

Narrower conditions

Vulvar Neoplasms (236)  ·  Uterine Cervical Neoplasms (156)  ·  Vaginal Neoplasms (114)  ·  Candidiasis, Vulvovaginal (107)  ·  Vulvodynia (107)  ·  Endometrial Neoplasms (74)  ·  Ovarian Neoplasms (72)  ·  Anus Neoplasms (46)  ·  Fallopian Tube Neoplasms (39)  ·  Vulvar Lichen Sclerosus (33)  ·  Breast Neoplasms (32)  ·  Penile Neoplasms (31)  ·  Uterine Neoplasms (31)  ·  Neoplasms (28)  ·  Vaginosis, Bacterial (27)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (501)  ·  Genital Diseases (501)  ·  Female Urogenital Diseases (499)  ·  Urogenital Diseases (499)  ·  Genital Diseases, Female (496)  ·  Neoplasms by Site (236)  ·  Urogenital Neoplasms (234)  ·  Vaginal Diseases (227)  ·  Genital Neoplasms, Female (226)  ·  Neoplasms (212)  ·  Uterine Diseases (164)  ·  Uterine Cervical Diseases (159)  ·  Infections (146)  ·  Vulvitis (132)

Interventions

Fluconazole (21)  ·  Radiotherapy (10)  ·  Cisplatin (9)  ·  Surveys and Questionnaires (9)  ·  Clobetasol (8)  ·  Clotrimazole (8)  ·  ibrexafungerp (8)  ·  Lidocaine (6)  ·  Methods (6)  ·  VT-1161 (6)  ·  pembrolizumab (6)  ·  Acupuncture Therapy (5)  ·  Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (5)  ·  Botulinum Toxins, Type A (4)  ·  Brachytherapy (4)

Sponsors

Merck Sharp & Dohme LLC (12)  ·  Gynecologic Oncology Group (11)  ·  M.D. Anderson Cancer Center (8)  ·  National Cancer Institute (NCI) (8)  ·  Scynexis, Inc. (8)  ·  Université de Sherbrooke (8)  ·  Western Galilee Hospital-Nahariya (7)  ·  Ohio State University Comprehensive Cancer Center (6)  ·  Corewell Health East (5)  ·  Dana-Farber Cancer Institute (5)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (5)  ·  Gedea Biotech AB (5)  ·  Karolinska Institutet (5)  ·  Northwestern University (5)  ·  Shanghai Bovax Biotechnology Co., Ltd. (5)

Countries

United States (207)  ·  Canada (34)  ·  China (31)  ·  United Kingdom (21)  ·  Italy (20)  ·  Sweden (20)  ·  France (19)  ·  Brazil (12)  ·  Turkey (Türkiye) (11)  ·  Germany (10)  ·  Spain (10)  ·  Israel (9)  ·  Switzerland (9)  ·  Austria (7)  ·  Poland (7)

Top investigators

Lori A Brotto, PhD (4)  ·  Anne Reb (3)  ·  Catherine Leclair, MD (3)  ·  Clare Shaw, Phd (3)  ·  David Angulo, MD (3)  ·  Fabien Pelletier, MD (3)  ·  Jacob Bornstein, MD (3)  ·  Shangrong Fan, M.D. (3)  ·  Yongjiang Liu, Bachelor (3)  ·  Alena Jandourek, MD (2)  ·  Allison M Quick, MD (2)  ·  Andrew T Goldstein, MD (2)

Results publications

PMID 36396498, PMID 27422279, PMID 19949018, PMID 20686386, PMID 22002018, PMID 23290987, PMID 29211620, PMID 29269325, PMID 29767739, PMID 32734597, PMID 33326342, PMID 33957642, PMID 36255448, PMID 38319878, PMID 40970688, PMID 10319301, PMID 15162347, PMID 16648432, PMID 17012991, PMID 17034521, PMID 17128343, PMID 18482765, PMID 18768432, PMID 18981976, PMID 19305326, PMID 19487487, PMID 19701032, PMID 20059663, PMID 20068553, PMID 20733439, PMID 22480131, PMID 22675922, PMID 22753905, PMID 22914465, PMID 23107862, PMID 23335087, PMID 23384847, PMID 23526734, PMID 23535473, PMID 23849695, PMID 24067488, PMID 24080300, PMID 24201015, PMID 24696010, PMID 24807329, PMID 25278227, PMID 25540035, PMID 25603224, PMID 25618900, PMID 25693011

NIH funding

2023 (6), P30CA033572 (3), U10CA027469 (3), U10CA101165 (3), U10CA180868 (3), 2009 (2), 2016 (2), 2017 (2), 2019 (2), P30CA012197 (2), R21CA293326 (2), UG1CA189867 (2), 2008 (1), 2014 (1), 2015 (1)